prof. Filip Van den Bosch
work address
De Pintelaan 185, 0K12-IB
9000 Gent
9000 Gent
1 – 10 of 81
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
- European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update
- American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis
- Gender-attributable differences in outcome of ankylosing spondylitis: long-term results from the Outcome in Ankylosing Spondylitis International Study
- Elevated calprotectin levels reveal bowel inflammation in spondyloarthritis
- Six-week treatment of axial spondyloarthritis patients with an optimal dose of nonsteroidal antiinflammatory drugs: early response to treatment in signal intensity on magnetic resonance imaging of the sacroiliac joints
- 2015
- Secukinumab, an interleukin-17A inhibitor, in ankylosing spondylitis
- Diagnostic value of MRI features of sacroiliitis in juvenile spondyloarthritis
- Diagnositic value of pelvic enthesitis on MRI of the sacroiliac joints in enthesitis related arthritis
- Secukinumab inhibition of interleukin-17A in patients with psoriatic arthritis
- Randomized controlled trial of adalimumab in patients with nonpsoriatic peripheral spondyloarthritis